Powered by

Allergan signs two deals in continued execution of 'stepping stone' strategy

Sep 20, 2016 - The Deal Pipeline

Allergan plc (AGN) has had a busy past few months, let alone a busy day as the Dublin-based pharma company announced a pair of deals Tuesday to acquire two separate companies both with a focus on liver disease treatment.

The Dublin-based pharmaceutical company announced after market close Tuesday, Sept. 20 that it will acquire privately held Encinitas, Calif.-based Arkana Therapeutics Ltd. for $50 million, as well as certain extra considerations based on the company reaching developmental ...